DEC 07, 2021 8:00 AM PST

Ancient Medicine and Synthetic Biology Collide to Combat Chemo Resistance

WRITTEN BY: Tara Fernandes

Strong chemical drugs used to obliterate all rapidly growing cells in the body have been used to treat cancer since the turn of the 20th century. While chemotherapy is still widely used in oncology, it isn't the best approach to cancer-killing—about 90 percent of cancer deaths result from tumors becoming resistant to the drugs.

Now, researchers at the University of Copenhagen are turning to ancient technologies for solutions. It's a plant that's only found in Australia and that has been used for its medicinal properties for thousands of years by Australian Aboriginal people. The plant (from the Eremophila genus) contains molecules that, when used in combination with chemotherapies, helps to inhibit tumor drug resistance.

The plant's active ingredient, a flavonoid, was tested in experimental lung and colon cancer models and was found to boost the efficacy of a chemotherapy called Irinotecan. This cancer drug uses an active ingredient called SN-38, a molecule that cancer cells have developed an ingenious way of resisting.

Tumors use a mechanism called an efflux pump to haul out chemo drugs from their cells, resulting in the drug's efficacy waning over time. The plant flavonoid inhibits the efflux pump, forcing SN-38 to remain localized within the cancer cells, eventually destroying them.

According to the researchers, nature holds the answers to many unknowns that continue to plague human health and wellbeing. Lead researcher Dan Stærk said: "The idea is to take traditional medicine knowledge, which has been passed on from generation to generation through thousands of years, and use advanced technology to determine which substances are active and which genes in the plants that code for the production of these active substances."



 

 

 

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
FEB 11, 2022
Plants & Animals
New Prostate Cancer Drug Effective in Dogs, Promising for Humans
FEB 11, 2022
New Prostate Cancer Drug Effective in Dogs, Promising for Humans
Prostate cancer affects about one in eight men each year, and is one of the most common types of cancer in men). Researc ...
FEB 20, 2022
Microbiology
An Intriguing Triad - Gut Fungus, Immunity, and Behavior
FEB 20, 2022
An Intriguing Triad - Gut Fungus, Immunity, and Behavior
Microbes in the gut have been shown to have a powerful influence on many aspects of our biology and well being. Scientis ...
MAR 07, 2022
Immunology
Newly Discovered T Cell Subset is Linked to Autoimmune Disease
MAR 07, 2022
Newly Discovered T Cell Subset is Linked to Autoimmune Disease
T cells are on the front lines of the immune system, and can work against infections and cancer cells. But the activity ...
MAR 10, 2022
Neuroscience
Light Alcohol Consumption Reduces Brain Volume
MAR 10, 2022
Light Alcohol Consumption Reduces Brain Volume
Drinking alcohol small quantities of alcohol- such as less than one unit, which is equivalent to half a beer- is linked ...
MAR 22, 2022
Technology
Reducing "Foreign Body Reactions" to Implantable Devices
MAR 22, 2022
Reducing "Foreign Body Reactions" to Implantable Devices
Implantable devices have proven useful for a range of health conditions. For example, pacemakers, implantable insulin pu ...
MAR 29, 2022
Drug Discovery & Development
Keto Diet Boosts Chemotherapy for Pancreatic Cancer
MAR 29, 2022
Keto Diet Boosts Chemotherapy for Pancreatic Cancer
A ketogenic diet- or a ‘keto’ diet- which is high in fat and low in protein and carbohydrates, may help kill ...
Loading Comments...